Lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1) has been identified as a major receptor for oxidized low-density lipoprotein (ox-LDL) in endothelial cells, monocytes, platelets, cardiomyocytes, and vascular smooth muscle cells. Its expression is minimal under physiological conditions but can be induced under pathological conditions. The upregulation of LOX-1 by ox-LDL appears to be important for physiologic processes, such as endothelial cell proliferation, apoptosis, and endothelium remodeling. Pathophysiologic effects of ox-LDL in atherogenesis have also been firmly established, including endothelial cell dysfunction, smooth muscle cell growth and migration, monocyte transformation into macrophages, and finally platelet aggregation—seen in atherogenesis. Recent studies show a positive correlation between increased serum ox-LDL levels and an increased risk of colon, breast, and ovarian cancer. As in atherosclerosis, ox-LDL and its receptor LOX-1 activate the inflammatory pathway through nuclear factor-kappa B, leading to cell transformation. LOX-1 is important for maintaining the transformed state in developmentally diverse cancer cell lines and for tumor growth, suggesting a molecular connection between atherogenesis and tumorigenesis. Antioxid. Redox Signal. 15, 2301–2333.
AbidMR, TsaiJC, SpokesKC, DeshpandeSS, IraniK, AirdWC. Vascular endothelial growth factor induces manganese-superoxide dismutase expression in endothelial cells by a Rac1-regulated NADPH oxidase-dependent mechanism. FASEB, 15:2548–2550. 2001.
2.
AdhikaryA, MohantyS, LahiryL, HossainD, ChakrabortyS, DasT. Theaflavins retard human breast cancer cell migration by inhibiting NF-κB via p53-ROS cross-talk. FEBS Lett, 584:7–14. 2010.
3.
Alo'PL, ViscaP, MarciA, MangoniA, BottiC, Di TondoU. Expression of fatty acid synthase (FAS) as a predictor of recurrence in stage I breast carcinoma patients. Cancer, 77:474–482. 1996.
ArnoldRS, HeJ, RemoA, RitsickD, Yin-GoenQ, LambethJD, DattaMW, YoungAN, PetrosJA. Nox1 expression determines cellular reactive oxygen and modulates c-fos-induced growth factor, interleukin-8, and Cav-1. Am J Pathol, 171:2021–2032. 2007.
6.
BahadoraniS, BahadoraniP, PhillipsJP, HillikerAJ. The effects of vitamin supplementation on Drosophila life span under normoxia and under oxidative stress. J Gerontol A Biol Sci Med Sci, 63:35–42. 2008.
7.
BakerK, MarcusCB, HuffmanK, KrukH, MalfroyB, DoctrowSR. Synthetic combined superoxide dismutase/catalase mimetics are protective as a delayed treatment in a rat stroke model: a key role for reactive oxygen species in ischemic brain injury. J Pharmacol Exp Ther, 284:215–221. 1998.
8.
BanchereauJ, BriereF, CauxC, DavoustJ, LebecqueS, LiuYJ, PulendranB, PaluckaK. Immunobiology of dendritic cells. Annu Rev Immunol, 18:767–811. 2000.
9.
BaranwalS, AlahariSK. Molecular mechanisms controlling E-cadherin expression in breast cancer. Biochem Biophys Res Commun, 384:6–11. 2009.
10.
BaronA, MigitaT, TangD, LodaM. Fatty acid synthase: a metabolic oncogene in prostate cancer?J Cell Biochem, 91:47–53. 2004.
11.
BasuroyS, BhattacharyaS, LefflerCW, ParfenovaH. Nox4 NADPH oxidase mediates oxidative stress and apoptosis caused by TNF-alpha in cerebral vascular endothelial cells. Am J Physiol Cell Physiol, 296:C422–C432. 2009.
BilletS, AguilarF, BaudryC, ClauserE. Role of angiotensin II AT1 receptor activation in cardiovascular diseases. Kidney Int, 74:1379–1384. 2008.
14.
BinderCJ, HartvigsenK, ChangMK, MillerM, BroideD, PalinskiW, CurtissLK, CorrM, WitztumJL. IL-5 links adaptive and natural immunity specific for epitopes of oxidized LDL and protects from atherosclerosis. J Clin Invest, 14:427–437. 2004.
15.
BinderRJ, SrivastavaPK. Peptides chaperoned by heat-shock proteins are a necessary and sufficient source of antigen in the cross-priming of CD8+ T cells. Nat Immunol, 6:593–599. 2005.
16.
BlackettAD, HallDA. Vitamin E—its significance in mouse ageing. Age Ageing, 10:191–195. 1981.
17.
BolliR, ZughaibM, LiXY, TangXL, SunJZ, TrianaJF, McCayPB. Recurrent ischemia in the canine heart causes recurrent bursts of free radical production that have a cumulative effect on contractile function. A pathophysiological basis for chronic myocardial "Stunning"J Clin Invest, 96:1066–1084. 1995.
18.
BragadoP, ArmesillaA, SilvaA, PorrasA. Apoptosis by cisplatin requires p53 mediated p38αMAPK activation through ROS generation. Apoptosis, 12:1733–1742. 2007.
19.
BuscheS, GallinatS, BohleRM, ReineckeA, SeebeckJ, FrrankeF, FinkF, ZhuM, SumnersC, UngerT. Expression of angiotesion AT (1) and AT (2) receptors in adult rat cardiomyocytes after myocardial in farction. A single-cell reverse transcriptase-polymerase chain reaction study. Am J Pathol, 157:605–611. 2000.
20.
BustosC, Hernández-PresaMA, OrtegoM, TuñónJ, OrtegaL, PérezF, DíazC, HernándezG, EgidoJ. HMG-CoA reductase inhibition by atorvastatin reduces neointimal inflammation in a rabbit model of atherosclerosis. J Am Coll Cardiol, 32:2057–2064. 1998.
21.
CaiJ, JiangWG, ManselRE. Phosphorylation and disorganization of vascular-endothelial cadherin in interaction between breast cancer and vascular endothelial cells. Int J Mol Med, 4:191–195. 1999.
22.
CalderwoodSK, CioccaDR. Heat shock proteins: stress proteins with Janus-like properties in cancer. Int J Hyperthermia, 24:31–39. 2008.
23.
CalderwoodSK, MambulaSS, GrayPJ.Jr.Extracellular heat shock proteins in cell signaling and immunity. Ann N Y Acad Sci, 1113:28–39. 2007.
24.
CalleEE, RodriguezC, Walker-ThurmondK, ThunMJ. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med, 348:1625–1638. 2003.
25.
CareyRM, WangZQ, SiragyHM. Role of the angiotensin type 2 receptor in the regulation of blood pressure and renal function. Hypertension, 35:155–163. 2000.
26.
CelermajerDS, SorensenKE, GoochVM, SpiegelhalterDJ, MillerOI, SullivanID, LloydJK, DeanfieldJE. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet, 340:1111–1115. 1992.
27.
ChabrashviliT, TojoA, OnozatoML, KitiyakaraC, QuinnMT, FujitaT, WelchWJ, WilcoxCS. Expression and cellular localization of classic NADPH oxidase subunits in the spontaneously hypertensive rat kidney. Hypertension, 39:269–274. 2002.
ChenHJ, LiDY, SaldeenT, PhillipsMI, MehtaJL. Attenuation of tissue P-selectin and MCP-1 expression and intimal proliferation by AT(1) receptor blockade in hyperlipidemic rabbits. Biochem Biophys Res Commun, 282:474–479. 2001.
32.
ChenHW, KuoCL, HuangCS, KuoSJ, LiuCS. Oxidized low-density lipoproteins, autoantibodies against oxidized low-density lipoproteins and carotid intima media thickness in a clinically healthy population. Cardiology, 110:252–259. 2008.
33.
ChenJ, LiD, SchaeferR, MehtaJL. Cross-talk between dyslipidemia and renin-angiotensin system and the role of LOX-1 and MAPK in atherogenesis studies with the combined use of rosuvastatin and candesartan. Atherosclerosis, 184:295–301. 2006.
34.
ChenJ, LiuY, LiuH, HermonatPL, MehtaJL. Lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1) transcriptional regulation by Oct-1 in human endothelial cells: implications for atherosclerosis. Biochem J, 393:255–265. 2006.
35.
ChenJ, LiuY, LiuH, HermonatPL, MehtaJL. Molecular dissection of angiotensin II-activated human LOX-1 promoter. Arterioscler Thromb Vasc Biol, 26:1163–1168. 2006.
36.
ChenJ, MehtaJL, ZhangX, SinghBK, LiD. Role of LOX-1 in expression of apoptotic proteins and activation of caspase pathways in human coronary artery endothelial cells. Circ Res, 94:370–376. 2004.
37.
ChenJ, MehtaJL. Angiotensin II-mediated oxidative stress and procollagen-1 expression in cardiac fibroblasts: blockade by pravastatin and pioglitazone. Am J Physiol Heart Circ Physiol, 291:H1738–H1745. 2006.
38.
ChenJ, MehtaJL. Interaction of oxidized low-density lipoprotein and the renin-angiotensin system in coronary artery disease. Curr Hypertens Rep, 8:139–143. 2006.
39.
ChenK, ChenJ, LiD, ZhangX, MehtaJL. Angiotensin II regulation of collagen type I expression in cardiac fibroblasts: modulation by PPAR-gamma ligand pioglitazone. Hypertension, 44:655–661. 2004.
40.
ChenK, ChenJ, LiuY, XieJ, LiD, SawamuraT, MehtaJL. Adhesion molecule expression in fibroblasts: alteration in fibroblast biology after transfection with LOX-1 plasmids. Hypertension, 46:622–627. 2005.
41.
ChenK, LiD, ZhangX, HermonatPL, MehtaJL. Anoxia-reoxygenation stimulates collagen type-I and MMP-1 expression in cardiac fibroblasts: modulation by the PPAR-gamma ligand pioglitazone. J Cardiovasc Pharmacol, 44:682–687. 2004.
42.
ChenK, MehtaJL, LiD, JosephL, JosephJ. Transforming growth factor beta receptor endoglin is expressed in cardiac fibroblasts and modulates profibrogenic actions of angiotensin II. Circ Res, 95:1167–1173. 2004.
43.
ChenL, HaughtWH, YangB, SaldeenTG, ParathasarathyS, MehtaJL. Preservation of endogenous antioxidant activity and inhibition of lipid peroxidation as common mechanisms of antiatherosclerotic effects of vitamin E, lovastatin and amlodipine. J Am Coll Cardiol, 30:569–575. 1997.
44.
ChenLY, MehtaP, MehtaJL. Oxidized LDL decreases L-arginine uptake and nitric oxide synthase protein expression in human platelets: relevance of the effect of oxidized LDL on platelet function. Circulation, 93:1740–1746. 1996.
45.
ChenM, InoueK, NarumiyaS, MasakiT, SawamuraT. Requirements of basic amino acid residues within the lectin-like domain of LOX-1 for the binding of oxidized low-density lipoprotein. FEBS Lett, 499:215–219. 2001.
46.
ChenM, KakutaniM, NarukoT. Activation-dependent surface expression of LOX-1 in human platelets. Biochem Biophys Res Commun, 282:153–158. 2001.
47.
ChenY, ZhuJ, LumPY, YangX, PintoS, MacNeilDJ, ZhangC, LambJ, EdwardsS, SiebertsSK. Variations in DNA elucidates molecular networks that cause disease. Nature, 452:429–435. 2008.
48.
ChengPY, LeeYM, ShihNL, ChenYC, YenMH. Heme oxygenase-1 contributes to the cytoprotection of alpha-lipoic acid via activation of p44/42 mitogen-activated protein kinase in vascular smooth muscle cells. Free Radic Biol Med, 40:1313–1322. 2006.
49.
ChobanianAV. The effects of ACE inhibitors and other antihypertensive drugs on cardiovascular risk factors and atherogenesis. Clin Cardiol, 13,6 Suppl 7:VII43–VII48. 1990.
50.
ClementiF, Di LuozzoM, MangoR, LucianiG, TrivisonnoA, PizzutoF, MartuscelliE, MehtaJL, RomeoF. Regression and shift in composition of coronary atherosclerotic plaques by pioglitazone: insight from an intravascular ultrasound analysis. J Cardiovasc Med (Hagerstown), 10:231–237. 2009.
51.
CohenM, DromardM, PetignatP. Heat shock proteins in ovarian cancer: a potential target for therapy. Gynecol Oncol, 119:164–166. 2010.
52.
ColesAH, GannonH, CernyA, Kurt-JonesE, JonesSN. Inhibitor of growth-4 promotes IkappaB promoter activation to suppress NF-kappaB signaling and innate immunity. Proc Natl Acad Sci USA, 107:11423–11428. 2010.
53.
CominaciniL, Fratta PasiniA, GarbinU, PastorinoA, RigoniA, NavaC, DavoliA, Lo CascioV, SawamuraT. The platelet-endothelium interaction mediated by lectin-like oxidized low-density lipoprotein receptor-1 reduces the intracellular concentration of nitric oxide in endothelial cells. J Am Coll Cardiol, 41:499–507. 2003.
54.
CominaciniL, PasiniAF, GarbinU, GarbinU, DavoliA, CampagnolaM, PastorinoAM, Lo CascioV, SawamuraT. Oxidized low density lipoprotein (ox-LDL) binding to ox-LDL receptor-1 in endothelial cells induces the activation of NF-κB through an increased production of intracellular reactive oxygen species. J Biol Chem, 275:12633–12638. 2000.
55.
CominaciniL, RigoniA, PasiniAF, GarbinU, DavoliA, CampagnolaM, PastorinoAM, Lo CascioV, SawamuraT. The binding of oxidized low density lipoprotein (ox-LDL) to ox-LDL receptor-1 reduces the intracellular concentration of nitric oxide in endothelial cells through an increased production of superoxide. J Biol Chem, 276:13750–13755. 2001.
56.
CsiszarA, LabinskyyN, ZhaoX, HuF, SerpillonS, HuangZ, BallabhP, LevyRJ, HintzeTH, WolinMS, AustadSN, PodlutskyA, UngvariZ. Vascular superoxide and hydrogen peroxide production and oxidative stress resistance in two closely related rodent species with disparate longevity. Aging Cell, 6:783–797. 2007.
57.
DandapatA, HuC, SunL, MehtaJL. Small concentrations of ox-LDL induce capillary tube formation from endothelial cells via LOX-1-dependent redox-sensitive pathway. Arterioscler Thromb Vasc Biol, 27:2435–2442. 2007.
DasS, KhanN, MukherjeeS, BagchiD, GurusamyN, SwartzH, DasDK. Redox regulation of resveratrol-mediated switching of death signal into survival signal. Free Radic Biol Med, 44:82–90. 2008.
60.
DekenXE, WangD, ManyMC, CostagliolaS, LibertF, VassartG, DumontJE, MiotF. Cloning of two human thyroid cdnas encoding new members of the NADPH oxidase family. J Biol Chem, 275:23227–23233. 2000.
61.
DelektorskayaVV, PerevoshchikovAG, GolovkovDA, KushlinskiiNE. Expression of E-cadherin, beta-catenin, and CD-44v6 cell adhesion molecules in primary tumors and metastases of colorectal adenocarcinoma. Bull Exp Biol Med, 139:706–710. 2005.
62.
den HengstWA, GielisJF, LinJY, Van SchilPE, De WindtLJ, MoensAL. Lung ischemia/reperfusion-injury: a molecular and clinical view on a complex pathophysiological process. Am J Physiol Heart Circ Physiol, 299:H1283–H1299. 2010.
DominguezJ, PattersonC. Oxidized LDL activates luminal LOX-1 in renal tubular cells and causes loss of barrier function. FASEB J, 21:lb581. 2007.
65.
DoyonP, ServantMJ. Tumor necrosis factor (TNF) receptor-associated factor-6 (TRAF6) and ribosomal s6 kinase (RSK) intracellular pathways link the angiotensin II AT1 receptor to the phosphorylation and activation of the I{kappa}B kinase complex in vascular smooth muscles cells. J Biol Chem, 285:30708–30718. 2010.
66.
DraudeG, LorenzRL. TGF-beta1 downregulates CD36 and scavenger receptor A but upregulates LOX-1 in human macrophages. Am J Physiol Heart Circ Physiol, 278:H1042–H1048. 2000.
67.
DunnS, VohraRS, MurphyJE, Homer-VanniasinkamS, WalkerJH, PonnambalamS. The lectin-like oxidized low-density-lipoprotein receptor: a pro-inflammatory factor in vascular disease. Biochem J, 409:349–355. 2008.
68.
EharaS, UedaM, NarukoT, HazeK, ItohA, OtsukaM, KomatsuR, MatsuoT, ItabeH, TakanoT, TsukamotoY, YoshiyamaM, TakeuchiK, YoshikawaJ, BeckerAE. Elevated levels of oxidized low density lipoprotein show a positive relationship with the severity of acute coronary syndromes. Circulation, 103:1955–1960. 2001.
69.
FalconBL, VeerasinghamSJ, SumnerC, RaizadaMK. Angiotension Π type 2 receptor- mediated gene expression profiling in human coronary artery endothelial cells. Hypertesion, 45:692–697. 2005.
70.
FanE, ZhangL, JiangS, BaiY. Beneficial effects of resveratrol on atherosclerosis. J Med Food, 11:610–614. 2008.
71.
FeoldeE, VigneP, FrelinC. Angiotensin Π receptor subtypes and biological response in the rat heart. J Mol Cell Cardiol, 25:1359–1367. 1993.
72.
FerrarioCM. Use of angiotensin II receptor blockers in animal models of atherosclerosis. Am J Hypertens, 15:9S–13S. 2002.
73.
FordWR, ClanachanAS, JugduttBI. Opposite effects of angiotensin AT1 and AT2 receptor antagonists on recovery of mechanical function after ischemia-reperfusion in isolated working rat hearts. Circulation, 94:3087–3089. 1996.
74.
FörstermannU, MüggeA, AlheidU, HaverichA, FrölichJC. Selective attenuation of endothelium-mediated vasodilation in atherosclerotic human coronary arteries. Circ Res, 62:185–190. 1988.
75.
FraleyAE, SchwartzGG, OlssonAG, KinlayS, SzarekM, RifaiN, LibbyP, GanzP, WitztumJL, TsimikasS. MIRACL Study Investigators. Relationship of oxidized phospholipids and biomarkers of oxidized low-density lipoprotein with cardiovascular risk factors, inflammatory biomarkers, and effect of statin therapy in patients with acute coronary syndromes: results from the MIRACL (Myocardial Ischemia Reduction With Aggressive Cholesterol Lowering) trial. J Am Coll Cardiol, 53:2186–2196. 2009.
76.
FruebisJ, BirdDA, PattisonJ, PalinskiW. Extent of antioxidant protection of plasma LDL is not a predictor of the antiatherogenic effect of antioxidants. J Lipid Res, 38:2455–2464. 1997.
77.
FruebisJ, CarewTE, PalinskiW. Effect of vitamin E on atherogenesis in LDL receptor-deficient rabbits. Atherosclerosis, 117:217–224. 1995.
78.
FuemmelerBF, PendzichMK, TercyakKP. Weight, dietary behavior, and physical activity in childhood and adolescence: implications for adult cancer risk. Obes Facts, 2:179–186. 2009.
79.
FujitaY, KakinoA, NishimichiN, YamaguchiS, SatoY, MachidaS, CominaciniL, DelnesteY, MatsudaH, SawamuraT. Oxidized LDL receptor LOX-1 binds to C-reactive protein and mediates its vascular effects. Clin Chem, 55:285–294. 2009.
80.
FukaoH, IjiriY, MiuraM, HashimotoM, YamashitaT, FukunagaC, OiwaK, KawaiY, SuwaM, YamamotoJ. Effect of trans-resveratrol on the thrombogenicity and atherogenicity in apolipoprotein E-deficient and low-density lipoprotein receptor-deficient mice. Blood Coagul Fibrinolysis, 15:441–446. 2004.
81.
GeisztM, LekstromK, BrennerS, HewittSM, DanaR, MalechHL, LetoTL. NAD(P)H Oxidase 1, a product of differentiated colon epithelial cells, can partially replace glycoprotein 91phox in the regulated production of superoxide by phagocytes. Immunology, 171:299–306. 2003.
82.
GerschmanR, GilbertDL, NyeSW, DwyenP, FennWO. Oxygen poisoning and x-irradiation: a mechanism in common. Science, 119:623–626. 1954.
GiovannucciE. Metabolic syndrome, hyperinsulinemia, and colon cancer: a review. Am J Clin Nutr, 86:836–842. 2007.
85.
GloireG, CharlierE, RahmouniS, VolantiC, ChariotA, ErneuxC, PietteJ. Restoration of SHIP-1 activity in human leukemic cells modifies NF-kappaB activation pathway and cellular survival upon oxidative stress. Oncogene, 25:5485–5494. 2006.
86.
GörlachE, FiaschiT, RamponiG, ChiarugiP. Redox regulation of anoikis resistance of metastatic prostate cancer cells: key role for Src and EGFR-mediated pro-survival signals. Oncogene, 28:2074–2086. 2009.
GrahamKA, KulawiecM, OwensKM, LiX, DesoukiMM, ChandraD, SinghKK. NADPH oxidase 4 is an oncoprotein localized to mitochondria. Cancer Biol Ther, 10:223–231. 2010.
89.
GroegerG, QuineyC, CotterTG. Hydrogen peroxide as a cell-survival signaling molecule. Antioxid Redox Signal, 11:2655–2671. 2009.
90.
GuoW, AhmedKM, HuiY, GuoG, LiJJ. SiRNA-mediated MDM2 inhibition sensitizes human lung cancer A549 cells to radiation. Int J Oncol, 30:1447–1452. 2007.
91.
GuthBD, MüllerTH. DTTX30, a combined thromboxane receptor antagonist and thromboxane synthetase inhibitor, prevents coronary thrombosis in anesthetized dogs. Basic Res Cardiol, 9:181–190. 1997.
92.
HarmanD. Aging: a theory based on free radical and radiation chemistry. J Gerontol, 11:298–300. 1956.
93.
HarrisonDG, FreimanPC, ArmstrongML, MarcusML, HeistadDD. Alterations of vascular reactivity in atherosclerosis. Circ Res, 61:II74–II80. 1987.
94.
HarrisonDG, GongoraMC. Oxidative stress and hypertension. Med Clin North Am, 93:621–635. 2009.
95.
HayashidaK, KumeN, MinamiM, KitaT. Lectin-like oxidized LDL receptor-1 (LOX-1) supports adhesion of mononuclear leukocytes and a monocyte-like cell line THP-1 cells under static and flow conditions. FEBS Lett, 511:133–138. 2002.
96.
HayashidaK, KumeN, MuraseT, MinamiM, NakagawaD, InadaT, TanakaM, UedaA, KominamiG, KambaraH, KimuraT, KitaT. Serum soluble lectin-like oxidized low-density lipoprotein receptor-1 levels are elevated in acute coronary syndrome: a novel marker for early diagnosis. Circulation, 112:812–818. 2005.
97.
HayashidaniS, TsutsuiH, ShiomiT, SuematsuN, KinugawaS, IdeT, WenJ, TakeshitaA. Fluvastatin, a 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor, attenuates left ventricular remodeling and failure after experimental myocardial infarction. Circulation, 105:868–873. 2002.
98.
HidaK, HidaY, ShindohM. Understanding tumor endothelial cell abnormalities to develop ideal anti-angiogenic therapies. Cancer Sci, 99:459–466. 2008.
99.
HinagataJ, KakutaniM, FujiiT, NarukoT, InoueN, FujitaY, MehtaJL, UedaM, SawamuraT. Oxidized LDL receptor LOX-1 is involved in neointimal hyperplasia after balloon arterial injury in a rat model. Cardiovasc Res, 69:263–271. 2006.
100.
HiraokaM, TaniguchiT, NakaiH, KinoM, OkadaY, TanizawaA, TsukaharaH, OhshimaY, MuramatsuI, MayumiM. No evidence for AT2R gene derangement in human urinary tract anomalies. Kidney Int, 29:1244–1249. 2001.
101.
HirschHA, IliopoulosD, JoshiA, ZhangY, JaegerSA, BulykM, TsichlisPN, Shirley LiuX, StruhlK. A transcriptional signature and common gene networks link cancer with lipid metabolism and diverse human diseases. Cancer Cell, 17:348–346. 2010.
102.
HirschHA, IliopoulosD, TsichlisPN, StruhlK. Metformin selectively targets cancer stem cells and acts together with chemotherapy to blocks tumor growth and prolong remission. Cancer Res, 69:7507–7511. 2009.
103.
HolvoetP, HarrisTB, TracyRP, VerhammeP, NewmanAB, RubinSM, SimonsickEM, ColbertLH, KritchevskySB. Association of high coronary heart disease risk status with circulating oxidized LDL in the well-functioning elderly: findings from the Health, Aging, and Body Composition study. Arterioscler Thromb Vasc Biol, 23:1444–1448. 2003.
104.
HolvoetP, MertensA, VerhammeP, BogaertsK, BeyensG, VerhaegheR, CollenD, MulsE, Van de WerfF. Circulating oxidized LDL is a useful marker for identifying patients with coronary artery disease. Arterioscler Thromb Vasc Biol, 21:844–888. 2001.
105.
HonjoM, NakamuraK, YamashiroK, KiryuJ, TaniharaH, McEvoyLM, HondaY, ButcherEC, MasakiT, SawamuraT. Lectin-like oxidized LDL receptor-1 is a cell-adhesion molecule involved in endotoxin-induced inflammation. PNAS, 100:1274–1279. 2003.
106.
HsiehHJ, ChengCC, WuST, ChiuJJ, WungBS, WangDL. Increase of reactive oxygen species (ROS) in endothelial cells by shear flow and involvement of ROS in shear-induced c-fos expression. J Cell Physiol, 175:156–162. 1998.
107.
HsuHY, ChiuSL, WenMH, ChenKY, HuaKF. Ligands of macrophage scavenger receptor induce cytokine expression via differential modulation of protein kinase signaling pathways. J Biol Chem, 276:28719–28730. 2001.
108.
HsuIR, KimSP, KabirM, BergmanRN. Metabolic syndrome, hyperinsulinemia, and cancer. Am J Clin Nutr, 86:867–871. 2007.
109.
HsuLA, KoYL, WuS, TengMS, ChouHH, ChangCJ, ChangPY. Association of soluble intercellular adhesion molecule-1 with insulin resistance and metabolic syndrome in Taiwanese. Metabolism, 58:983–988. 2009.
HuC, DandapatA, ChenJ, LiuY, HermonatPL, CareyRM, MehtaJL. Over-expression of angiotensin II type 2 receptor (agtr2) reduces atherogenesis and modulates LOX-1, endothelial nitric oxide synthase and heme-oxygenase-1 expression. Atherosclerosis, 199:284–294. 2008.
112.
HuC, DandapatA, MehtaJL. Angiotensin II induces capillary formation from endothelial cells via the LOX-1 dependent redox-sensitive pathway. Hypertension, 50:952–957. 2007.
113.
HuC, DandapatA, SunL, ChenJ, MarwaliMR, RomeoF, SawamuraT, MehtaJL. LOX-1 deletion decreases collagen accumulation in atherosclerotic plaque in low-density lipoprotein receptor knockout mice fed a high-cholesterol diet. Cardiovasc Res, 79:287–293. 2008.
HuC, KangBY, MegyesiJ, KaushalGP, SafirsteinRL, MehtaJL. Deletion of LOX-1 attenuates renal injury following angiotensin II infusion. Kidney Int, 76:521–527. 2009.
116.
HuCP, DandapatA, LiuY, HermonatPL, MehtaJL. Blockade of hypoxia-reoxygenation-mediated collagen type I expression and MMP activity by overexpression of TGF-beta1 delivered by AAV in mouse cardiomyocytes. Am J Physiol Heart Circ Physiol, 293:H1833–H1838. 2007.
117.
HuT, RamachandraraoSP, SivaS, ValanciusC, ZhuY, MahadevK, TohI, GoldsteinBJ, WoolkalisM, SharmaK. Reactive oxygen species production via NADPH oxidase mediates TGF-beta-induced cytoskeletal alterations in endothelial cells. Am J Physiol Renal Physiol, 289:F816–F825. 2005.
IraniK, XiaY, ZweierJL, ScollotSJ, DerCJ, FearonER, SundaresanM, FinkelT, Goldschmidt-ClermontPJ. Mitogenic signaling mediated by oxidants in Ras-transformed fibroblasts. Science, 275:1649–1652. 1997.
120.
JeroudiMO, HartleyCJ, BolliR. Myocardial reperfusion injury: role of oxygen radicals and potential therapy with antioxidants. Am J Cardiol, 73:2B–7B. 1994.
121.
JialalI, DevarajS. Vitamin E supplementation and cardiovascular events in high risk patients. N Engl J Med, 342:1917–1918. 2000.
122.
JöhrerK, JankeK, KrugmannJ, FieglM, GreilR. Transendothelial migration of myeloma cells is increased by tumor necrosis factor (TNF)-alpha via TNF receptor 2 and autocrine up-regulation of MCP-1. Clin Cancer Res, 10:1901–1910. 2004.
KamataH, ManabeT, OkaS, KamataK, HirataH. Hydrogen peroxide activate IkappaB kinases through phosphorylation of serine residues in the activation loops. FEBS Lett, 519:231–237. 2002.
126.
KamataT. Roles of Nox1 and other Nox isoforms in cancer development. Cancer Sci, 100:1382–1388. 2009.
127.
KangBY, HuC, PrayagaS, KhaidakovM, SawamuraT, SeungKB, MehtaJL. LOX-1 dependent overexpression of immunoglobulins in cardiomyocytes in response to angiotensin II. Biochem Biophys Res Commun, 379:395–399. 2009.
128.
KangBY, HuC, RyuS, KhanJA, BiancolellaM, PrayagaS, SeungKB, NovelliG, MehtaP, MehtaJL. Genomics of cardiac remodeling in angiotensin II-treated wild-type and LOX-1-deficient mice. Physiol Genomics, 42:42–54. 2010.
KangBY, MehtaJL. Rosuvastatin attenuates Ang II-mediated cardiomyocyte hypertrophy via inhibition of LOX-1. J Cardiovasc Pharmacol Ther, 14:283–291. 2009.
131.
KashiwaseK, HiguchiY, HirotaniS, YamaguchiO, HikosoS, TakedaT, WatanabeT, TaniikeM, NakaiA, TsujimotoI, MatsumuraY, UenoH, NishidaK, HoriM, OtsuK. CaMKII activates ASK1 and NF-kappaB to induce cardiomyocyte hypertrophy. Biochem Biophys Res Commun, 327:136–142. 2005.
132.
Kataja-TuomolaMK, KonttoJP, MännistöS, AlbanesD, VirtamoJR. Effect of alpha-tocopherol and beta-carotene supplementation on macrovascular complications and total mortality from diabetes: results of the ATBC Study. Ann Med, 42:178–186. 2010.
133.
KeidarS, AttiasJ. Angiotensin II injection into mice increases the uptake of oxidized LDL by their mcrophages via a proteoglycan-mediated pathway. Biochem Biophys Res Commun, 239:63–67. 1997.
134.
KeidarS, KaplanM, HoffmanA, AviramM. Angiotnsin II stimulates macrophages-mediated oxidation of low density lipoproteins. Atherosclerosis, 115:201–215. 1995.
135.
KhromovaNV, KopninPB, StepanovaEV, AgapovaLS, KopninBP. p53 hot-spot mutants increase tumor vascularization via ROS-mediated activation of the HIF1/VEGF-A pathway. Cancer Lett, 276:143–151. 2009.
KongJY, RabkinSW. Angiotensin II does not induce apoptosis but rather prevents apoptosis in cardiomyocytes. Peptides, 21:1237–1247. 2000.
140.
KumarB, KoulS, KhandrikaL, MeachamRB, KoulHK. Oxidative stress is inherent in prostate cancer cells and is required for aggressive phenotype. Cancer Res, 68:1777–1785. 2008.
141.
Kumar-SinhaC, IgnatoskiKW, LippmanME, EthierSP, ChinnaiyanAM. Transcriptome analysis of HER2 reveals a molecular connection to fatty acid synthesis. Cancer Res, 63:132–139. 2003.
142.
KumeN, MitsuokaH, HayashidaK, TanakaM, KominamiG, KitaT. Soluble lectin-like oxidized LDL receptor-1 (sLOX-1) as a sensitive and specific biomarker for acute coronary syndrome—comparison with other biomarkers. J Cardiol, 56:159–165. 2010.
KusakabeTet al.Fatty acid synthase is expressed mainly in adult hormone-sensitive cells or cells with high lipid metabolism and in proliferating fetal cells. J Histochem Cytochem, 48:613–622. 2000.
145.
LappalainenJ, LindstedtKA, OksjokiR, KovanenPT. OxLDL-IgG immune complexes induce expression and secretion of proatherogenic cytokines by cultured human mast cells. Atherosclerosis, 214:357–363. 2011.
146.
LarssonSC, MantzorosCS, WolkA. Diabetes mellitus and risk of breast cancer: a meta-analysis. Int. J. Cancer, 121:856–862. 2007.
147.
LeeCF, LiuCY, ChenSM, SikorskaM, LinCY, ChenTL, WeiYH. Attenuation of UV-induced apoptosis by coenzyme Q10 in human cells harboring large-scale deletion of mitochondrial DNA. Ann N Y Acad Sci, 1042:429–438. 2005.
148.
LeeCF, QiaoM, SchröderK, ZhaoQ, AsmisR. Nox4 is a novel inducible source of reactive oxygen species in monocytes and macrophages and mediates oxidized low density lipoprotein-induced macrophage death. Circ Res, 106:1489–1497. 2010.
149.
LeeWJ, OuHC, HsuWC, ChouMM, TsengJJ, HsuSL, TsaiKL, SheuWH. Ellagic acid inhibits oxidized LDL-mediated LOX-1 expression, ROS generation, and inflammation in human endothelial cells. J Vasc Surg, 52:1290–300. 2010.
150.
LeeYH, NairS, RousseauE, AllisonDB, PageGP, TataranniPA, BogardusC, PermanaPA. Microarray profiling of isolated abdominal subcutaneous adipocytes from obese vs non-obese Pima Indians: increased expression of inflammation-related genes. Diabetologia, 48:1776–1783. 2005.
151.
LiD, LiuL, ChenH, SawamuraT, MehtaJL. LOX-1, an oxidized LDL endothelial receptor, induces CD40/CD40L signaling in human coronary artery endothelial cells. Arterioscler Thromb Vasc Biol, 23:816–821. 2003.
152.
LiD, MehtaJL. Antisense to LOX-1 inhibits oxidized LDL-mediated upregulation of monocyte chemoattractant protein-1 and monocyte adhesion to human coronary artery endothelial cells. Circulation, 101:2889–2895. 2000.
153.
LiD, MehtaJL. Intracellular signaling of LOX-1 in endothelial cell apoptosis. Circ Res, 104:566–568. 2009.
154.
LiD, MehtaJL. Ox-LDL induces apoptosis in human coronary artery endothelial cells: role of PKC, PTK, bcl-2, and Fas. Am J Physiol, 275:H568–H576. 1998.
155.
LiD, MehtaJL. Upregulation of endothelial receptor for oxidized LDL (LOX-1) by oxidized LDL and implications in apoptosis of human coronary artery endothelial cells: evidence from use of antisense LOX-1 mRNA and chemical inhibitors. Arterioscler Thromb Vasc Biol, 20:1116–1122. 2000.
156.
LiD, PatelAR, KlibanovAL, KramerCM, RuizM, KangBY, MehtaJL, BellerGA, GloverDK, MeyerCH. Molecular imaging of atherosclerotic plaques targeted to oxidized LDL receptor LOX-1 by SPECT/CT and magnetic resonance. Circ Cardiovasc Imaging, 3:464–472. 2010.
157.
LiD, SaldeenT, RomeoF, MehtaJL. Oxidized LDL upregulates angiotensin II type 1 receptor expression in cultured human coronary artery endothelial cells: the potential role of transcription factor NF-kappaB. Circulation, 102:1970–1976. 2000.
158.
LiD, WilliamsV, LiuL, ChenH, SawamuraT, AntakliT, MehtaJL. LOX-1 inhibition in myocardial ischemia-reperfusion injury: modulation of MMP-1 and inflammation. Am J Physiol Heart Circ Physiol, 283:H1795–H1801. 2002.
159.
LiD, WilliamsV, LiuL, ChenH, SawamuraT, RomeoF, MehtaJL. Expression of lectin-like oxidized low-density lipoprotein receptors during ischemia-reperfusion and its role in determination of apoptosis and left ventricular dysfunction. J Am Coll Cardiol, 41:1048–1055. 2003.
160.
LiD, ZhangYC, PhilipsMI, SawamuraT, MehtaJL. Upregulation of endothelial receptor for oxidized low-density lipoprotein (LOX-1) in cultured human coronary artery endothelial cells by angiotensin II type 1 receptor activation. Circ Res, 84:1043–1049. 1999.
161.
LiDY, ChenHJ, MehtaJL. Statins inhibit oxidized-LDL-mediated LOX-1 expression, uptake of oxidized-LDL and reduction in PKB phosphorylation. Cardiovasc Res, 52:5–7. 2001.
162.
LiDY, SaldeenT, MehtaJL. γ-tocopherol decreases ox-LDL-mediated activation of nuclear factor-κB and apoptosis in human coronary artery endothelial cells. Biochem Biophys Res Commun, 259:157–161. 1999.
163.
LiH, QiY, LiC, BrasethLN, GaoY, ShabashviliAE, KatovichMJ, SumnersC. Angiotensin type 2 receptor-mediated apoptosis of human prostate cancer cells. Mol Cancer Ther, 8:3255–3265. 2009.
164.
LiJ, DingSF, HabibNA, FermorBF, WoodCB, GilmourRS. Partial characterization of a cDNA for human stearoyl-CoA desaturase and changes in its mRNA expression in some normal and malignant tissues. Int J Cancer, 57:348–352. 1994.
165.
LiJ, FanL, GeorgeV, BrooksG. Nox2 regulates endothelial cell cycle arrest and apoptosis via p21cip1 and p53. Free Radic Biol Med, 43:976–986. 2007.
166.
LiJ, HiroseN, KawamuraM, AraiY. Antiatherogenic effect of angiotensin converting enzyme inhibitor (benazepril) and angiotensin II receptor antagonist (valsartan) in the cholesterol-fed rabbits. Atherosclerosis, 143:315–326. 1999.
167.
LiL, SawamuraT, RenierG. Glucose enhances endothelial LOX-1 expression: role for LOX-1 in glucose-induced human monocyte adhesion to endothelium. Diabetes, 52:1843–1850. 2003.
168.
LiR, HuangL, GuoH, TooleBP. Basigin (murine EMMPRIN) stimulates matrix metalloproteinase production by fibroblasts. J Cell Physiol, 186:371–379. 2001.
169.
LiangM, ZhangP, FuJ. Up-regulation of LOX-1 expression by TNF-alpha promotes trans-endothelial migration of MDA-MB-231 breast cancer cells. Cancer Lett, 258:31–37. 2007.
170.
LindL. Arterial compliance and endothelium-dependent vasodilation are independently related to coronary risk in the elderly: the Prospective Investigation of the Vasculature in Uppsala Seniors (PIVUS) study. Clin Physiol Funct Imaging, 28:373–377. 2008.
171.
LiouGY, StorzP. Reactive oxygen species in cancer. Free Radic Res, 44:479–496. 2010.
172.
LonnE, BoschJ, YusufS, SheridanP, PogueJ, ArnoldJM, RossC, ArnoldA, SleightP, ProbstfieldJ, DagenaisGR. HOPE and HOPE-TOO Trial Investigators. Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial. JAMA, 293:1338–1347. 2005.
173.
LoukogeorgakisSP, van den BergMJ, SofatR, NitschD, CharakidaM, HaiyeeB, de GrootE, MacAllisterRJ, KuijpersTW, DeanfieldJE. Role of NADPH oxidase in endothelial ischemia/reperfusion injury in humans. Circulation, 121:2310–2316. 2010.
174.
LuJ, PeiH, KaeckM, ThompsonHJ. Gene expression changes associated with chemically induced rat mammary carcinogenesis. Mol Carcinog, 20:204–215. 1997.
175.
LuJ, YangJ-H, BurnsAR, ChenH-H, TangD, WalterscheidJP, SuzukiS, YangC-Y, SawamuraT, ChenC-H. Mediation of electronegative low-density lipoprotein signaling by LOX-1. A possible mechanism of endothelial apoptosis. Circ Res, 104:619–627. 2009.
176.
LuWJ, LeeNP, FatimaS, LukJM. Heat shock proteins in cancer: signaling pathways, tumor markers and molecular targets in liver malignancy. Protein Pept Lett, 16:508–516. 2009.
177.
LuY, ChenQ, CoreyE, XieW, FanJ, MizokamiA, ZhangJ. Activation of MCP-1/CCR2 axis promotes prostate cancer growth in bone. Clin Exp Metastasis, 26:161–169. 2009.
178.
MaLP, KangMF, YinSM, NieDN, XieSF, WuYD, LiYQ, FengJH, XuLZ. The effects of pravastatin on platelet-derived nitric oxide system in rabbits. Zhonghua Xue Ye Xue Za Zhi, 26:539–542. 2005.
179.
ManeaA, TanaseL I, RaicuM, SimionescuM. JAK/STAT signaling pathway regulates Nox1 and Nox4-based NADPH oxidase in human aortic smooth muscle cells. Arterioscler Thromb Vasc Biol, 30:105–112. 2010.
180.
MangoR, BioccaS, del VecchioF, ClementiF, SangiuoloF, AmatiF, FilaretoA, GrelliS, SpitalieriP, FilesiI, FavalliC, LauroR, MehtaJL, RomeoF, NovelliG. In vivo and in vitro studies support that a new splicing isoform of OLR1 gene is protective against acute myocardial infarction. Circ Res, 97:152–158. 2005.
181.
ManjiliMH, WangXY, ParkJ, FacciponteJG, RepaskyEA, SubjeckJR. Immunotherapy of cancer using heat shock proteins. Front Biosci, 7:d43–d52. 2002.
182.
ManriqueC, LastraG, HabibiJ, WeiY, MorrisEM, StumpCS, SowersJR. Methods in the evaluation of cardiovascular renin angiotensin aldosterone activation and oxidative stress. Methods Mol Med, 139:163–179. 2007.
MarwaliMR, HuCP, MohandasB, DandapatA, DeonikarP, ChenJ, CawichI, SawamuraT, KavdiaM, MehtaJL. Modulation of ADP-induced platelet activation by aspirin and pravastatin: role of lectin-like oxidized low-density lipoprotein receptor-1, nitric oxide, oxidative stress, and inside-out integrin signaling. J Pharmacol Exp Ther, 22:1324–1332. 2007.
185.
MatsunagaT, HokariS, KoyamaI, HaradaT, Komoda. TNF-kappa B activation in endothelial cells treated with oxidized high-density lipoprotein. Biochem Biophys Res Commun, 303:313–319. 2003.
186.
MatsutakeT, SawamuraT, SrivastavaPK. High efficiency CD91- and LOX-1-mediated re-presentation of gp96-chaperoned peptides by MHC II molecules. Cancer Immun, 10:7. 2010.
187.
MedesG, ThomasA, WeinhouseS. Metabolism of neoplastic tissue. IV. A study of lipid synthesis in neoplastic tissue slices in vitro. Cancer Res, 13:27–29. 1953.
188.
MehtaJL, ChenJ, HermonatPL, RomeoF, NovelliG. Lectin-like, oxidized low-density lipoprotein receptor-1 (LOX-1): a critical player in the development of atherosclerosis and related disorders. Cardiovasc Res, 69:36–45. 2006.
189.
MehtaJL, HuB, ChenJW, LiDY. Pioglitazone inhibits LOX-1 expression in human coronary artery endothelial cells by reducing intracellular superoxide radical generation. Arterioscler Thromb Vasc Biol, 23:2203–2208. 2003.
190.
MehtaJL, LiD. Identification, regulation and function of a novel lectin-like oxidized low-density lipoprotein receptor. J Am Coll Cardiol, 39:1429–1435. 2002.
191.
MehtaJL, LiDY. Identification and autoregulation of receptor for ox-LDL in cultured human coronary artery endothelial cells. Biochem Biophys Res Commun, 248:511–514. 1998.
192.
MehtaJL, NicholsWW, DonnellyWH, LawsonDL, ThompsonL, ter RietM, SaldeenTG. Protection by superoxide dismutase from myocardial dysfunction and attenuation of vasodilator reserve after coronary occlusion and reperfusion in dog. Circ Res, 65:1283–1295. 1989.
193.
MehtaJL, RasouliN, SinhaA, MolaviB. Oxidative stress in diabetes: Basis of its adverse cardiac effects. Int J Biochem Cell Biol, 38:794–803. 2006.
MehtaJL, YangB, KerenskyRA, ContiCR. Potential therapeutic implications of the phenomenon of ischemic preconditioning of the myocardium: lessons from the animal and catheterization laboratories. Am J Cardiol, 74:1270–1271. 1994.
197.
MehtaJL. Oxidized or native low-density lipoprotein cholesterol: which is more important in atherogenesis?J Am Coll Cardiol, 48:980–982. 2006.
198.
MehtaPK, GriendlingKK. Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system. J Physiol Cell Physiol, 292:C82–C97. 2007.
199.
MelovS, RavenscroftJ, MalikS, GillMS, WalkerDW, ClaytonPE, WallaceDC, MalfroyB, DoctrowSR, LithgowGJ. Extension of life-span with superoxide dismutase/catalase mimetics. Science, 289:1567–1569. 2000.
200.
MengL, KohnKW, PommierY. Dose–response transition from cell cycle arrest to apoptosis with selective degradation of Mdm2 and p21WAF1/CIP1 in response to the novel anticancer agent, aminoflavone. Oncogene, 26:4806–4816. 2007.
201.
MigitaT, RuizS, FornariA, FiorentinoM, PrioloC, ZadraG, InazukaF, GrisanzioC, PalescandoloE, ShinE, FioreC, XieW, KungAL, FebboPG, SubramanianA, MucciL, MaJ, SignorettiS, StampferM, HahnWC, FinnS, LodaM. Fatty acid synthase: a metabolic enzyme and candidate oncogene in prostate cancer. J Natl Cancer Inst, 101:519–532. 2009.
202.
MillerTW, IsenbergJS, RobertsDD. Molecular regulation of tumor angiogenesis and perfusion via redox signaling. Chem Rev, 109:3099–3124. 2009.
203.
MinamiM, KumeN, KataokaH, MorimotoM, HayashidaK, SawamuraT, MasakiT, KitaT. Transforming growth factor-beta(1) increases the expression of lectin-like oxidized low-density lipoprotein receptor-1. Biochem Biophys Res Commun, 272:357–361. 2000.
204.
MitraS, LuJ, MehtaJL. Ox-LDL and atherosclerosis. Am J Med Sci, 2011(in press).
205.
MitsushitaJ, LambethJD, KamataT. The superoxide-generating oxidase Nox1 is functionally required for Ras oncogene transformation. Cancer Res, 64:3580–3585. 2004.
206.
MizutaniK, IkedaK, YamoriY. Resveratrol inhibits AGEs-induced proliferation and collagen synthesis activity in vascular smooth muscle cells from stroke-prone spontaneously hypertensive rats. Biochem Biophys Res Commun, 274:61–67. 2000.
207.
MorawietzH, RueckschlossU, NiemannB, DuerrschmidtN, GalleJ, HakimK, ZerkowskiHR, SawamuraT, HoltzJ. Angiotensin II induces LOX-1, the human endothelial receptor for oxidized low-density lipoprotein. Circulation, 100:899–902. 1999.
208.
MorleyAA, TrainorKJ. Lack of an effect of vitamin E on lifespan of mice. Biogerontology, 2:109–112. 2001.
209.
MoudgilR, Musat-MarcuS, XuY, KumarD, JugduttBI. Increased AT2R protein expression but not increased apoptosis during cardioprotection in induced by AT1R blockade. Can J Cardiol, 18:873–883. 2002.
210.
MuniyappaH, SongS, MathewsCK, DasKC. Reactive oxygen species-independent oxidation of thioredoxin in hypoxia: inactivation of ribonucleotide reductase and redox-mediated checkpoint control. J Biol Chem, 284:17069–17081. 2009.
211.
MuscoliC, SaccoI, AlecceW, PalmaE, NisticòR, CostaN, ClementiF, RotirotiD, RomeoF, SalveminiD, MehtaJL, MollaceV. The protective effect of superoxide dismutase mimetic M40401 on balloon injury-related neointima formation: role of the lectin-like oxidized low-density lipoprotein receptor-1. J Pharmacol Exp Ther, 311:44–50. 2004.
212.
NagaseM, HiroseS, SawamuraT, MasakiT, FujitaT. Enhanced expression of endothelial oxidized low-density lipoprotein receptor (LOX-1) in hypertensive rats. Biochem Biophys Res Commun, 237:496–498. 1997.
213.
NagaseM, KanameS, NagaseTet al.Expression of LOX-1, an oxidized low-density lipoprotein receptor, in experimental hypertensive glomerulosclerosis. J Am Soc Nephrol, 11:1826–1836. 2000.
214.
NavabM, AnanthramaiahGM, ReddyST, Van LentenBJ, AnsellBJ, FonarowGC, VahabzadehK, HamaS, HoughG, KamranpourN, BerlinerJA, LusisAJ, FogelmanAM. The oxidation hypothesis of atherogenesis: the role of oxidized phospholipids and HDL. J Lipid Res, 45:993–1007. 2004.
215.
NavabM, BerlinerJA, SubbanagounderG, HamaS, LusisAJ, CastellaniLW, ReddyS, ShihD, ShiW, WatsonAD, Van LentenBJ, VoraD, FogelmanAM. HDL and the inflammatory response induced by LDL-derived oxidized phospholipids. Arterioscler Thromb Vasc Biol, 21:481–488. 2001.
216.
NavarroA, GómezC, Sánchez-PinoMJ, GonzálezH, BándezMJ, BoverisAD, BoverisA. Vitamin E at high doses improves survival, neurological performance, and brain mitochondrial function in aging male mice. Am J Physiol Regul Integr Comp Physiol, 289:R1392–R1399. 2005.
217.
NichollsSJ, WangZ, KoethR, LevisonB, DelFrainoB, DzavikV, GriffithOW, HathawayD, PanzaJA, NissenSE, HochmanJS, HazenSL. Metabolic profiling of arginine and nitric oxide pathways predicts hemodynamic abnormalities and mortality in patients with cardiogenic shock after acute myocardial infarction. Circulation, 116:2315–2324. 2007.
218.
ObikaneH, AbikoY, UenoH, KusumiY, EsumiM, MitsumataM. Effect of endothelial cell proliferation on atherogenesis: a role of p21 (Sdi/Cip/Waf1) in monocyte adhesion to endothelial cells. Atherosclerosis, 212:116–122. 2010.
219.
O'BrienWJ, KremaC, HeimannT, ZhaoH. Expression of NADPH oxidase in rabbit corneal epithelial and stromal cells in culture. Invest Ophthalmol Vis Sci, 47:853–863. 2006.
OttoJ, OrdovasJM, SmithD, van DongenD, NicolosiRJ, SchaeferEJ. Lovastatin inhibits diet induced atherosclerosis in F1B golden Syrian hamsters. Atherosclerosis, 114:19–28. 1995.
223.
PalinskiW, HörkköS, MillerE, SteinbrecherUP, PowellHC, CurtissLK, WitztumJL. Cloning of monoclonal autoantibodies to epitopes of oxidized lipoproteins from apolipoprotein E-deficient mice. Demonstration of epitopes of oxidized low density lipoprotein in human plasma. J Clin Invest, 98:800–814. 1996.
224.
PallottiniV, MartiniC, PascoliniA, CavalliniG, GoriZ, BergaminiE, IncerpiS, TrentalanceA. 3-Hydroxy-3-methylglutaryl coenzyme A reductase deregulation and age-related hypercholesterolemia: a new role for ROS. Mech Ageing Dev, 126:845–851. 2005.
225.
PapatheodorouL, WeissN. Vascular oxidant stress and inflammation in hyperhomocysteinemia. Antioxid Redox Signal, 9:1941–1958. 2007.
226.
ParlatoS, RomagnoliG, SpadaroF, CaniniI, SirabellaP, BorghiP, RamoniC, FilesiI, BioccaS, GabrieleL, BelardelliF. LOX-1 as a natural IFN-alpha-mediated signal for apoptotic cell uptake and antigen presentation in dendritic cells. Blood, 115:1554–1563. 2010.
227.
PatelPB, PfauSE, ClemanMW, BrennanJJ, HowesC, RemetzM, CabinHS, SetaroJF, RinderHM. Comparison of coronary artery specific leukocyte-platelet conjugate formation in unstable versus stable angina pectoris. Am J Cardiol, 93:410–413. 2004.
PolovinaM, PotparaT, GigaV, OstojićM. Significance of heterogenity in endothelium-dependent vasodilatation occurrence in healthy individuals with or without coronary risk factors. Vojnosanit Pregl, 66:813–820. 2009(Serbian.)
231.
PowersSK, MurlasitsZ, WuM, KavazisAN. Ischemia-reperfusion-induced cardiac injury: a brief review. Med Sci Sports Exerc, 39:1529–1536. 2007.
232.
PucaR, NardinocchiL, StaraceG, RechaviG, SacchiA, GivolD, D'OraziG. Nox1 is involved in p53 deacetylation and suppression of its transcriptional activity and apoptosis. Free Radic Biol Med, 48:1338–1346. 2010.
233.
QiY, LiH, MeccaA, ShenoyV, SumnersC, KatovichMJ. Overexpression of angiotensin II type receptor (AT2R) in neonatal cardiomyocytes induces apoptosis. FASEB J, 22:1238.18. 2008.
234.
RanfordJC, CoatesAR, HendersonB. Chaperonins are cell-signalling proteins: the unfolding biology of molecular chaperones. Expert Rev Mol Med, 2:1–17. 2000.
235.
RanjanP, AnathyV, BurchPM, WeiratherK, LambethJD, HeintzNH. Redox-dependent expression of cyclin D1 and cell proliferation by Nox1 in mouse lung epithelial cells. Antioxid Redox Signal, 8:1447–1459. 2006.
236.
RaviD, MuniyappaH, DasKC. Endogenous thioredoxin is required for redox cycling of anthracyclines and p53-dependent apoptosis in cancer cells. J Biol Chem, 280:40084–40096. 2005.
237.
ReckelhoffJF, KanjiV, RacusenLC, SchmidtAM, YanSD, MarrowJ, RobertsLJ2nd, SalahudeenAK. Vitamin E ameliorates enhanced renal lipid peroxidation and accumulation of F2-isoprostanes in aging kidneys. Am J Physiol, 274:R767–R774. 1998.
238.
ReddyRK, DubeauL, KleinerH, ParrT, NicholsP, KoB, DongD, KoH, MaoC, DiGiovanniJ, LeeAS. Cancer-inducible transgene expression by the Grp94 promoter: spontaneous activation in tumors of various origins and cancer-associated macrophages. Cancer Res, 62:7207–7212. 2002.
239.
RobertJ, MénoretA, CohenN. Cell surface expression of the endoplasmic reticular heat shock protein gp96 is phylogenetically conserved. J Immunol, 163:4133–4139. 1999.
240.
SakamotoN, IshibashiT, SugimotoK, SakamotoT, OhkawaraH, SawamuraT, InoueN, TakeishiY. LOX-1 mediates rennin-angiotensin system-dependent redox-sensitive and Ca2+ signaling pathways induced in endothelial cells by monocyte adhesion. Circulation, 120:S617. 2009.
241.
SakamotoN, IshibashiT, SugimotoK, SawamuraT, SakamotoT, InoueN, SaitohS, KamiokaM, UekitaH, OhkawaraH, SuzukiK, TeramotoT, MaruyamaY, TakeishiY. Role of LOX-1 in monocyte adhesion-triggered redox, Akt/eNOS and Ca2+ signaling pathways in endothelial cells. J Cell Physiol, 220:706–715. 2009.
242.
SasakiM, JohT. Oxidative stress and ischemia-reperfusion injury in gastrointestinal tract and antioxidant, protective agents. J Clin Biochem Nutr, 40:1–12. 2007.
ScagliaN, IgalRA. Inhibition of Stearoyl-CoA Desaturase 1 expression in human lung adenocarcinoma cells impairs tumorigenesis. Int J Oncol, 33:839–850. 2008.
245.
SchwarzerC, MachenTE, IllekB, FischerH. NADPH oxidase-dependent acid production in airway epithelial cells. J Biol Chem, 279:36454–36461. 2004.
246.
SecchieroP, CoralliniF, GonelliA, Dell'EvaR, VitaleM, CapitaniS, AlbiniA, ZauliG. Antiangiogenic activity of the MDM2 antagonist Nutlin-3. Circ Res, 100:61–69. 2007.
247.
SegevA, StraussBH, WitztumJL, LauHK, TsimikasS. Relationship of a comprehensive panel of plasma oxidized low-density lipoprotein markers to angiographic restenosis in patients undergoing percutaneous coronary intervention for stable angina. Am Heart J, 150:1007–1014. 2005.
248.
SellkeFW, ArmstrongML, HarrisonDG. Endothelium-dependent vascular relaxation is abnormal in the coronary microcirculation of atherosclerotic primates. Circulation, 81:1586–1593. 1990.
249.
ShahUS, DhirR, GollinSM, ChandranUR, LewisD, AcquafondataM, PflugBR. Fatty acid synthase gene overexpression and copy number gain in prostate adenocarcinoma. Hum Pathol, 37:401–409. 2006.
250.
ShihHH, ZhangS, CaoW, HahnA, WangJ, PaulsenJE, HarnishDC. CRP is a novel ligand for the oxidized LDL receptor LOX-1. Am J Physiol Heart Circ Physiol, 296:H1643–H1650. 2009.
251.
ShurbajiMS, KalbfleischJH, ThurmondTS. Immunohistochemical detection of a fatty acid synthase (OA-519) as a predictor of progression of prostate cancer. Hum Pathol, 27:917–921. 1996.
252.
SinghBM, MehtaJL. Interactions between the renin-angiotensin system and dyslipidemia: relevance in the therapy of hypertension and coronary heart disease. Arch Intern Med, 163:1296–1304. 2003.
253.
SluimerJC, KistersN, CleutjensKB, VolgerOL, HorrevoetsAJ, van den AkkerLH, BijnensAP, DaemenMJ. Dead or alive: gene expression profiles of advanced atherosclerotic plaques from autopsy and surgery. Physiol Genomics, 30:335–341. 2007.
254.
StommelJ, WahlG. Accelerated MDM2 auto-degradation induced by DNA-damage kinases is required for p53 activation. EMBO, 23:1547–1556. 2004.
255.
SugimotoK, IshibashiT, SawamuraT, InoueN, KamiokaM, UekitaH, OhkawaraH, SakamotoT, SakamotoN, OkamotoY, TakuwaY, KakinoA, FujitaY, TanakaT, TeramotoT, MaruyamaY, TakeishiY. LOX-1-MT1-MMP axis is crucial for RhoA and Rac1 activation induced by oxidized low-density lipoprotein in endothelial cells. Cardiovasc Res, 84:127–136. 2009.
256.
SuhYA, ArnoldRS, LassegueB, ShiJ, XuX, SorescuD, ChungAB, GriendlingKK, LambethJD. Cell transformation by the superoxide-generating oxidase Mox1. Nature, 401:79–82. 1999.
257.
Sumitomo-UedaY, AiharaK, IseT, YoshidaS, IkedaY, UemotoR, YagiS, IwaseT, IshikawaK, HirataY, AkaikeM, SataM, KatoS, MatsumotoT. Heparin cofactor II protects against angiotensin II-induced cardiac remodeling via attenuation of oxidative stress in mice. Hypertension, 56:430–436. 2010.
258.
SurekhaRH, SrikanthBB, JharnaP, RamachandraRV, DayasagarRV, JyothyA. Oxidative stress and total antioxidant status in myocardial infarction. Singapore Med J, 48:137–142. 2007.
259.
TakabeW, LiR, AiL, YuF, BerlinerJA, HsiaiTK. Oxidized low-density lipoprotein-activated c-Jun NH2-terminal kinase regulates manganese superoxide dismutase ubiquitination: implication for mitochondrial redox status and apoptosis. Arterioscler Thromb Vasc Biol, 30:436–441. 2010.
260.
Takanabe-MoriR, OnoK, SowaN, WadaH, TakayaT, HorieT, Satoh-AsaharaN, ShimatsuA, FujitaM, SawamuraT, HasegawaK. LOX-1 is required for the adipose tissue expression of proinflammatory cytokines in high-fat diet-induced obese mice. Biochem Biophys Res Commun, 398:576–580. 2010.
261.
TanNY, LiJM, StockerR, KhachigianLM. Angiotensin II-inducible smooth muscle cell apoptosis involves the angiotensin II type 2 receptor, GATA-6 activation, and Fasl-Fas engagement. Circ Res, 105:422–430. 2009.
262.
TandonS, BhargavaK, GuptaH, BansalM, KasliwalRR. Non-invasive assessment of endothelial function by brachial artery flow mediated vasodilatation and its association with coronary artery disease: an Indian perspective. J Indian Med Assoc, 102:243–246–251–252. 2004.
263.
TatsuguchiM, FurutaniM, HinagataJ, TanakaT, FurutaniY, ImamuraS, KawanaM, MasakiT, KasanukiH, SawamuraT, MatsuokaR. Oxidized LDL receptor gene (OLR1) is associated with the risk of myocardial infarction. Biochem Biophys Res Commun, 303:247–250. 2003.
264.
TayeA, SaadAH, KumarAH, MorawietzH. Effect of apocynin on NADPH oxidase-mediated oxidative stress-LOX-1-eNOS pathway in human endothelial cells exposed to high glucose. Eur J Pharmacol, 627:42–48. 2010.
265.
TeslovichTM, MusunuruKet al.Biological, clinical and population relevance of 95 loci for blood lipids. Nature, 466:707–713. 2010.
266.
The Acute Infarction Ramipril Efficacy (AIRE) Study Investigators. Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. Lancet, 342:821–828. 1993.
267.
The SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med, 325:293–302. 1991.
268.
ThériaultJR, AdachiH, CalderwoodSK. Role of scavenger receptors in the binding and internalization of heat shock protein 70. J Immunol, 177:8604–8611. 2006.
269.
ThumT, BorlakJ. LOX-1 Receptor blockade abrogates oxLDL-induced oxidative DNA damage and prevents activation of the transcriptional repressor Oct-1 in human coronary arterial endothelium. J Biol Chem, 28:19456–19464. 2008.
270.
TouyzRM, BrionesAM. Reactive oxygen species and vascular biology: implications in human hypertension. Hypertens Res, 34:5–14. 2011.
271.
TsimikasS, BergmarkC, BeyerRW, PatelR, PattisonJ, MillerE, JulianoJ, WitztumJL. Temporal increases in plasma markers of oxidized low-density lipoprotein strongly reflect the presence of acute coronary syndromes. J Am Coll Cardiol, 41:360–370. 2003.
272.
TsutsuiT, TsutamotoT, WadaA, MaedaK, MabuchiN, HayashiM, OhnishiM, KinoshitaM. Plasma oxidized low-density lipoprotein as a prognostic predictor in patients with chronic congestive heart failure. J Am Coll Cardiol, 39:957–962. 2002.
273.
TurocziT, ChangVW, EngelmanRM, MaulikN, HoYS, DasDK. Thioredoxin redox signaling in the ischemic heart: an insight with transgenic mice overexpressing Trx1. J Mol Cell Cardiol, 35:695–704. 2003.
274.
UtsugiT, SchroitAJ, ConnorJ, BucanaCD, FidlerIJ. Elevated Expression of Phosphatidylserine in the outer membrane leaflet of human tumor cells and recognition by activated human blood monocytes. Cancer Res, 51:3062–3066. 1991.
275.
VabulasRM, BraedelS, HilfN, Singh-JasujaH, HerterS, Ahmad-NejadP, KirschningCJ, Da CostaC, RammenseeHG, WagnerH, SchildH. The endoplasmic reticulum-resident heat shock protein Gp96 activates dendritic cells via the Toll-like receptor 2/4 pathway. J Biol Chem, 277:20847–20853. 2002.
276.
van EdenW, HogervorstEJ, WaubenMH, van der ZeeR, BoogCJ. Heat-shock proteins as antigens in autoimmunity. Biochem Soc Trans, 19:171–175. 1991.
277.
ViscaP, SebastianiV, BottiC, DiodoroMG, LasagniRP, RomagnoliF, BrennaA, De JoannonBC, DonnorsoRP, LombardiG, AloPL. Fatty acid synthase (FAS) is a marker of increased risk of recurrence in lung carcinoma. Anticancer Res, 24:4169–4173. 2004.
278.
WangC, JayadevS, EscobedoJA. Identification of a domain in the angiotension Π type 1 receptor determing Gq coupling by the use of receptor chimeras. J Biol Chem, 270:16677–16682. 1995.
279.
WangHB, LiuXP, LiangJ, YangK, SuiAH, LiuYJ. Expression of RhoA and RhoC in olorectal carcinoma and its relations with clinicopathological parameters. Clin Chem Lab Med, 47:811–817. 2009.
280.
WatanabeT, BarkerTA, BerkBC. Angiotensin II and the endothelium. Diverse signals and effects. Hypertension, 45:163–169. 2005.
281.
WatanabeY, ItoT, ShiomiM, TsujitaY, KurodaM, AraiM, FukamiM, TamuraA. Preventive effect of pravastatin sodium, a potent inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase, on coronary atherosclerosis and xanthoma in WHHL rabbits. Biochim Biophys Acta, 960:294–302. 1988.
282.
Whaley-ConnellA, GovindarajanG, HaydenMR, CopperSA, WeiY, MaL, QaziM, LinkD, KarupathiPR, StumpCS, FerrarioCM, SowersJR. Angiotension Π-mediated oxidative stress promotes myocardial tissue remodeling in the transgenic TG (mRen2)27 Ren2 rat. Am J Physiol Endocrinol Metab, 293:E355–E363. 2007.
283.
Whaley-ConnellA, HabibiJ, CopperSA, DeMarcoVG, HaydenMR, StumpCS, LinkD, FerrarioCM, SowersJR. Effect of renin inhibition and AT1R blockade on myocardial remodeling in the transgenic Ren2 rat. Am J Physiol Endocrinol Metab, 295:E103–E109. 2008.
284.
WuT, WillettWC, RifaiN, ShaiI, MansonJE, RimmEB. Is plasma oxidized low-density lipoprotein, measured with the widely used antibody 4E6, an independent predictor of coronary heart disease among U.S. men and women?J Am Coll Cardiol, 48:973–979. 2006.
285.
XieJ, ZhuH, GuoL, RuanY, WangL, SunL, ZhouL, WuW, YunX, ShenA, GuJ. Lectin-like oxidized low-density lipoprotein receptor-1 delivers heat shock protein 60-fused antigen into the MHC class I presentation pathway. J Immunol, 185:2306–2313. 2010.
286.
YangYA, HanWF, MorinPJ, ChrestFJ, PizerES. Regulation of fatty acid synthase expression in breast cancer by sterol regulatory element binding protein-1c. Exp Cell Res, 282:132–137. 2003.
287.
YuW, FuYC, ChenCJ, WangX, WangW. SIRT1: a novel target to prevent atherosclerosis. J Cell Biochem, 108:10–13. 2009.
ZenK, LiuDQ, GuoYL, WangC, ShanJ, FangM, ZhangCY, LiuY. CD44v4 is a major E-selectin ligand that mediates breast cancer cell transendothelial migration. PLoS One, 3:e1826. 2008.
ZhangY, BissingJW, XuLet al.Nitric oxide synthase inhibitors decrease coronary sinus-free radical concentration and ameliorate myocardial stunning in an ischemia-reperfusion model. J Am Coll Cardiol, 38:546–554. 2001.
292.
ZhuHL, XiaM, HouMJ, TangZH, ZhengPY, LingWH. Effects of LOX-1 on expression of adhesion molecules induced by ox-LDL in HUVECs. Zhonghua Xin Xue Guan Bing Za Zhi, 33:743–747. 2005.
293.
ZouJG, WangZR, HuangYZ, CaoKJ, WuJM. Effect of red wine and wine polyphenol resveratrol on endothelial function in hypercholesterolemic rabbits. Int J Mol Med, 11:317–320. 2003.
